Account
BookMyShow brings Publicis co Starcom on board as media partner
MUMBAI: Publicis company Starcom has won the media mandate of BookMyShow. The mandate includes print, television, radio, cinema and outdoor.
BookMyShow is an online entertainment ticketing platform that allows users to book tickets for movies, plays, sports and live events through its website, mobile app and mobile site. Founded in Mumbai in 1999 and launched in 2007, BookMyShow is now present in over 650 towns and cities across India.
Says Mallikarjun Das, Group CEO, Starcom India, “The Starcom approach is to drive human actions and thereby business outcomes through transformative experiences and data-driven communication. BookMyShow is expanding rapidly and we look forward to unlocking new consumer connections for them and delivering bang for the buck on their media investments. We will provide them with agile solutions and help them achieve maximum exposure and eyeballs.”
Marzdi Kalianiwala, VP- Business Intelligence and Marketing, BookMyShow said, “We look forward to benefiting from Starcom’s experience and expertise in integrated communication strategies. We have always kept our users at the centre of our universe and as we scale and embark on new and exciting opportunities, we are confident that together with Starcom we will be able to reach out to our users more effectively and efficiently.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
